Croda International PLC (CRDA)

9,104.0
+32.0(+0.35%)
  • Volume:
    41,026
  • Bid/Ask:
    9,102.0/9,104.0
  • Day's Range:
    9,066.0 - 9,148.0

CRDA Overview

Prev. Close
9,072
Day's Range
9,066-9,148
Revenue
2.32B
Open
9,088
52 wk Range
5,843.1-9,358
EPS
1.81
Volume
41,026
Market Cap
12.56B
Dividend (Yield)
95.00
(1.03%)
Average Volume (3m)
239,046
P/E Ratio
50.18
Beta
0.51
1-Year Change
46.32%
Shares Outstanding
138,412,975
Next Earnings Date
02 Nov 2021
What is your sentiment on Croda International PLC?
or
Vote to see community's results!

Croda International PLC News

Croda International PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuySellBuyStrong Buy
Technical IndicatorsBuyStrong BuySellStrong SellStrong Buy
SummaryBuyStrong BuySellNeutralStrong Buy

Croda International PLC Company Profile

Croda International PLC Company Profile

Employees
5684

Croda International Plc is a United Kingdom-based specialty chemical company. Its marketing and research activities are organized into four global market sectors: Personal Care, Life Sciences, Performance Technologies and Industrial Chemicals. Personal Care sector focuses on ingredients for skin, hair, sun protection and color cosmetic products. Life Sciences sector comprises three businesses, Health Care, Crop Protection and Seed Enhancement. Performance Technologies sector targets technologies in Smart Materials and Energy Technologies and develops in Home Care & Water. Industrial Chemicals sector focuses on developing applications, selling co-streams and undertaking toll processing. It manufactures fragrances and flavours. Its products and markets include adhesives, agrochemicals, beauty and personal care, dietary supplements, food ingredients, furniture and wood, lubricants, oleochemicals, paints and coatings, pharmaceuticals, polymers and additives, skin health and water treatment

Read More
  • +6% today. Great company with a strong future.
    0
    • Excellent article in Shares Magazine ,01/04/2021, about Croda this week, worth a read. Pfizer contract a new revenue stream plus MRNA vaccines related work . chemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.Investors should buychemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.chemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.Investors should buychemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.
      0
      • very expensive
        2
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.